Home Tags Biophaermaceuticals
Leerink Capital Partners has appointed former Wilshire Private Markets senior executive Karl Beinkampen as president.
Cressey & Company has closed its oversubscribed Fund VI on its $995m hard cap as well as drawing in $105m through a related co-investment vehicle.
TFO Synapse Venture Fund I has raised $18m for a venture capital fund targeting $100m, according to a SEC filing.
Northleaf Capital Partners has secured a 40% stake in Lal Lal Wind Farms, two wind generation projects in Australia from Macquarie Capital.
Michigan-based buyout house Lorient Capital has aimed to raise $122m for its latest healthcare fund.
Deal sourcing intelligence business Sutton Place Strategies crunches the numbers on the ongoing trend for PE firms closing fewer and fewer deals, despite originating more and more.